UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Selective C‐Reactive Protein‐Apheresis in Patients

Therapeutic apheresis and dialysis, 2019-12, Vol.23 (6), p.570-574

2019

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study

Frontiers in cardiovascular medicine, 2021-03, Vol.8, p.591714-591714

2021

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein and Coronary Heart Disease: All Said-Is Not It?

Mediators of Inflammation, 2014-01, Vol.2014 (7), p.757123-7

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons

Journal of clinical medicine, 2022-03, Vol.11 (7), p.1771

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

Journal of clinical medicine, 2022-03, Vol.11 (7), p.1762

2022

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein in Human Atherogenesis: Facts and Fiction

Mediators of Inflammation, 2014-01, Vol.2014 (5), p.561428-6

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models

Mediators of Inflammation, 2014-01, Vol.2014 (3), p.353614-9

2014

Link zum Volltext

Verfügbarkeit prüfen

Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction-Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study

Journal of clinical medicine, 2022-10, Vol.11 (21), p.6446

2022

Link zum Volltext

Verfügbarkeit prüfen

Recognition Functions of Pentameric C-Reactive Protein in Cardiovascular Disease

Mediators of Inflammation, 2014-01, Vol.2014 (3), p.319215-6

2014

Link zum Volltext

Verfügbarkeit prüfen

Animal Models of C-Reactive Protein

Mediators of Inflammation, 2014-01, Vol.2014 (6), p.683598-7

2014

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein and Arteriosclerosis

Mediators of Inflammation, 2014-01, Vol.2014 (6), p.646817-1

2014

Link zum Volltext

Verfügbarkeit prüfen

Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance

Journal of cardiovascular development and disease, 2023-07, Vol.10 (7), p.294

2023

Link zum Volltext

Verfügbarkeit prüfen

“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction

Case reports in cardiology, 2018-01, Vol.2018, p.1-4

2018

Link zum Volltext

Verfügbarkeit prüfen

Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of ≤18 mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)

International journal of cardiology. Heart & vasculature, 2020-04, Vol.27, p.100501-100501, Article 100501

2020

Link zum Volltext

Verfügbarkeit prüfen

TCT-214 The Total Amount of C-Reactive Protein Within the First 72 Hours After STEMI Is Crucial for the Outcome

Journal of the American College of Cardiology, 2021-11, Vol.78 (19), p.B87-B88

2021

Link zum Volltext

Verfügbarkeit prüfen

Successful Use of mRNA‐Nucleofection for Overexpression of Interleukin‐10 in Murine Monocytes/Macrophages for Anti‐inflammatory Therapy in a Murine Model of Autoimmune Myocarditis

Journal of the American Heart Association, 2012-12, Vol.1 (6), p.e003293-n/a

2012

Link zum Volltext

Verfügbarkeit prüfen

A short review on CRP synthesis inhibition in cardiovascular disease

Frontiers in drug discovery, 2024-03, Vol.4

2024

Link zum Volltext

Verfügbarkeit prüfen

Interferon β-1b Therapy in Chronic Viral Dilated Cardiomyopathy—Is There a Role for Specific Therapy?

Journal of cardiac failure, 2010-04, Vol.16 (4), p.348-356

2010

Link zum Volltext

Verfügbarkeit prüfen

Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy

European journal of heart failure, 2006-03, Vol.8 (2), p.162-166

2006

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein and Atherogenesis: New Insights from Established Animal Models

The American journal of pathology, 2005-10, Vol.167 (4), p.923-925

Torzewski, Jan

2005

Link zum Volltext

Verfügbarkeit prüfen

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1530-1540

2018

Link zum Volltext

Verfügbarkeit prüfen

TCT-117 Performance and Safety of the Resorbable Magnesium Scaffold, Magmaris, in a Real-World Setting: Primary and Secondary Endpoint Analysis of the Full Cohort (2,066 Subjects) of the BIOSOLVE-IV Registry

Journal of the American College of Cardiology, 2021-11, Vol.78 (19), p.B49-B49

2021

Link zum Volltext

Verfügbarkeit prüfen

TCT-61 Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting—24-Month Follow-up of the Full Cohort (2,066 subjects) of the BIOSOLVE-IV Registry

Journal of the American College of Cardiology, 2022-09, Vol.80 (12), p.B25

2022

Link zum Volltext

Verfügbarkeit prüfen

BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients

Catheterization and cardiovascular interventions, 2021-07, Vol.98 (1), p.E1-E8

2021

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive protein-mediated low density lipoprotein uptake by macrophages : Implications for atherosclerosis

Circulation (New York, N.Y.), 2001-03, Vol.103 (9), p.1194-1197

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(97)
Berichte
(1)

Sprache

Englisch
(98)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Selective C‐Reactive Protein‐Apheresis in Patients

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study

C-Reactive Protein and Coronary Heart Disease: All Said-Is Not It?

Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

C-Reactive Protein in Human Atherogenesis: Facts and Fiction

Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models

Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction-Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study

Recognition Functions of Pentameric C-Reactive Protein in Cardiovascular Disease

Animal Models of C-Reactive Protein

C-Reactive Protein and Arteriosclerosis

Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance

“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction

Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of ≤18 mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)

TCT-214 The Total Amount of C-Reactive Protein Within the First 72 Hours After STEMI Is Crucial for the Outcome

Successful Use of mRNA‐Nucleofection for Overexpression of Interleukin‐10 in Murine Monocytes/Macrophages for Anti‐inflammatory Therapy in a Murine Model of Autoimmune Myocarditis

A short review on CRP synthesis inhibition in cardiovascular disease

Interferon β-1b Therapy in Chronic Viral Dilated Cardiomyopathy—Is There a Role for Specific Therapy?

Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy

C-Reactive Protein and Atherogenesis: New Insights from Established Animal Models

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

TCT-117 Performance and Safety of the Resorbable Magnesium Scaffold, Magmaris, in a Real-World Setting: Primary and Secondary Endpoint Analysis of the Full Cohort (2,066 Subjects) of the BIOSOLVE-IV Registry

TCT-61 Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting—24-Month Follow-up of the Full Cohort (2,066 subjects) of the BIOSOLVE-IV Registry

BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients

C-Reactive protein-mediated low density lipoprotein uptake by macrophages : Implications for atherosclerosis

Suchergebnisse filtern